Human therapeutics company Amgen has succeeded in preventing rival Roche from launching its anaemia drug Mircera in the US, after a jury in the US Federal District Court in Boston found that the drug ...

ZURICH, May 25 (Reuters) - Roche Holding AG's potential blockbuster drug Mircera has been cleared by European authorities, who recommended allowing sales to treat anaemia linked to kidney disease.

Basel, 17 July 2006 - For the first time, clinical studies show that dialysis patients treated with short-acting and frequently administered epoetin anti-anaemia drugs can be directly switched to a ...

When it comes to product development, the management of third-party intellectual property (IP) to ensure freedom to operate is of paramount importance. Drug development is no different. Imagine ...

Law360 (December 23, 2009, 2:40 PM EST) -- A federal judge has enjoined Swiss drugmaker Hoffmann-La Roche Inc. from selling its anemia drug Mircera in the U.S. until mid-2014 following a settlement ...

Akebia is awaiting the outcome from an FDA appeal for vadadustat for treating anemia in chronic kidney disease patients who depend on dialysis. (Grigorenko ...